Sirolimus Injections for Autoimmune Scleritis

NCT01517074 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

5

Enrollment

NIH

Sponsor class

Conditions

Scleritis

Interventions

DRUG: Sirolimus

Sponsor

National Eye Institute (NEI)